Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Raben

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
DNA and Cell Biology|November 22, 2002
Helios gene gun particle delivery for therapy of acid maltase deficiencyFrank Martiniuk, Agnes Chen, Adra Mack, et al.
Orphanet Journal of Rare Diseases|June 22, 2013
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapySean N Prater, Trusha T Patel, Anne F Buckley, et al.
Arthritis and Rheumatism|July 20, 2011
The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damageHeather M Alger, Nina Raben, Emidio Pistilli, et al.
Acta Neuropathologica Communications|January 4, 2014
The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patientsErin J Feeney, Stephanie Austin, Yin-Hsiu Chien, et al.
EMBO Molecular Medicine|April 23, 2013
Transcription factor EB (TFEB) is a new therapeutic target for Pompe diseaseCarmine Spampanato, Erin Feeney, Lishu Li, et al.
Journal of Neuropathology and Experimental Neurology|July 24, 2008
Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease miceRichard L Sidman, Tatyana Taksir, Jonathan Fidler, et al.
Autophagy|May 13, 2016
TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophagesNunzia Pastore, Owen A Brady, Heba I Diab, et al.
Human Molecular Genetics|December 5, 2009
Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe diseaseGaelle Douillard-Guilloux, Nina Raben, Shoichi Takikita, et al.
Autophagy|September 24, 2010
Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder--murine Pompe diseaseNina Raben, Cynthia Schreiner, Rebecca Baum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibersNina Raben, Tokiko Fukuda, Abigail L Gilbert, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
DNA and Cell Biology|November 22, 2002
Helios gene gun particle delivery for therapy of acid maltase deficiencyFrank Martiniuk, Agnes Chen, Adra Mack, et al.
Orphanet Journal of Rare Diseases|June 22, 2013
Skeletal muscle pathology of infantile Pompe disease during long-term enzyme replacement therapySean N Prater, Trusha T Patel, Anne F Buckley, et al.
Arthritis and Rheumatism|July 20, 2011
The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damageHeather M Alger, Nina Raben, Emidio Pistilli, et al.
Acta Neuropathologica Communications|January 4, 2014
The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patientsErin J Feeney, Stephanie Austin, Yin-Hsiu Chien, et al.
EMBO Molecular Medicine|April 23, 2013
Transcription factor EB (TFEB) is a new therapeutic target for Pompe diseaseCarmine Spampanato, Erin Feeney, Lishu Li, et al.
Journal of Neuropathology and Experimental Neurology|July 24, 2008
Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease miceRichard L Sidman, Tatyana Taksir, Jonathan Fidler, et al.
Autophagy|May 13, 2016
TFEB and TFE3 cooperate in the regulation of the innate immune response in activated macrophagesNunzia Pastore, Owen A Brady, Heba I Diab, et al.
Human Molecular Genetics|December 5, 2009
Restoration of muscle functionality by genetic suppression of glycogen synthesis in a murine model of Pompe diseaseGaelle Douillard-Guilloux, Nina Raben, Shoichi Takikita, et al.
Autophagy|September 24, 2010
Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder--murine Pompe diseaseNina Raben, Cynthia Schreiner, Rebecca Baum, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 9, 2004
Replacing acid alpha-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibersNina Raben, Tokiko Fukuda, Abigail L Gilbert, et al.
Pageof 8